Hemispherx BioPharma, Inc (NYSEAMERICAN:HEB – Get Free Report)’s stock price crossed above its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of $0.00 and traded as high as $0.14. Hemispherx BioPharma shares last traded at $0.13, with a volume of 1,462,716 shares traded.
Hemispherx BioPharma Stock Performance
The stock has a 50 day moving average price of $0.18.
About Hemispherx BioPharma
Hemispherx Biopharma, Inc, a specialty pharmaceutical company, engages in the clinical development of drug therapies based on natural immune system enhancing technologies for the treatment of viral and immune based chronic disorders in the United States. The company's products include Alferon N Injection, an injectable formulation of natural alpha interferon to treat a category of genital warts, a sexually transmitted disease; and Ampligen for the treatment of chronic fatigue syndrome (CFS).
Featured Articles
- Five stocks we like better than Hemispherx BioPharma
- How to Short Nasdaq: An Easy-to-Follow Guide
- Ignore Reports, Apple Won’t Install Starlink with iOS 18.3
- Bank Stocks – Best Bank Stocks to Invest In
- Casey’s Uptrend Remains Strong—New Highs on the Horizon
- What is a Secondary Public Offering? What Investors Need to Know
- Taiwan Semiconductor’s Huge U.S. Move—Stock Impact Ahead
Receive News & Ratings for Hemispherx BioPharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hemispherx BioPharma and related companies with MarketBeat.com's FREE daily email newsletter.
